Clinicopathological characteristics and outcome analysis of patients with double primary ovarian cancer and endometrial cancer

Author:

Li Fangyu1,Guo Yongzhen1,Zhang Xiwen2,Dong Xing1,Pei Xiaoyin1,Ban Zhenying1

Affiliation:

1. Third Affiliated Hospital of Zhengzhou University

2. Third Affiliated Hospital of Guangzhou Medical University

Abstract

Abstract

Ovarian cancer (OC) and endometrial cancer (EC) are two female reproductive system tumors with high incidence rates. However, the clinicopathological characteristics of double primary OC and EC have been less studied. In this study, we aimed to identify some predictive and prognostic factors for synchronous endometrial and ovarian cancer (SEOC) by comparing survival outcomes between SEOC and single-primary OC patients.Clinical data were collected from 447 patients in the Surveillance, Epidemiology, and End Results (SEER) database who were diagnosed with OC as the first primary tumor and EC (8380/3, 8382/3, 8383/3) as the second primary tumor from 2010 to 2015. Survival outcome was estimated using Kaplan-Meier survival curves and compared using the log-rank test. Univariate and multivariate analyses were conducted utilizing COX models to identify their independent prognostic factors. A total of 447 SEOC patients and 20,769 single primary OC patients between 2010 and 2015 were included in this study. dual-primary group has more survival benefits than single-primary group. Age, marital status, histological typing, tumor size and tumor SEER stage and AJCC stage were independent factors affecting the prognosis of patients with double primary. Our study demonstrated that the clinicopathologic features of OC patients in the dual-primary group were young (43–55 years old), highly/moderately differentiated endometrioid ovarian cancer, and early-stage tumors. The prognosis of these patients was better than that of the single-primary group. These findings contribute to a better understanding of the differences between SEOC and single primary OC, and can help inform the development of more precise treatment guidelines to improve prognosis.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3